Screening and Monitoring for Eating Disorders in Youth Presenting for Obesity Treatment
Abstract
Eating disorders (EDs) are serious brain-based disorders manifesting as maladaptive eating- and weight-related behaviors accompanied by distressing cognitions/attitudes and serious medical complications which may occur in individuals at any weight. The American Academy of Pediatrics (AAP) 2023 clinical practice guideline for managing pediatric obesity1 highlighted that EDs may present in youth seeking weight management. This publication raised awareness that pediatricians need increased knowledge on EDs in youth with elevated body mass index (BMI; kg/m2) to ensure safe, high-quality care. Specific areas of critical concern include inadequate familiarity with the prevalence and presentations of EDs in youth at higher weights, lack of a validated screening tool for EDs in children and adolescents, and knowledge gaps around medical risks of youth at higher weights who develop restrictive eating disorders. This perspectives piece aims to assist pediatricians who treat youth at higher weights in critically reviewing the 2023 AAP guidelines on obesity, to improve ED detection and intervention.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.